Drugs & supplements recalls
Prescription medicines, over-the-counter products and compounded drugs withdrawn from distribution.
-
Class II · last month
OurPharma LLC fentaNYL Citrate, 1,000 mcg/100 mL Injection solution in 100 mL recall: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and…
-
Class II · last month
Golden State Medical Supply Inc. Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle recall: Failed Dissolution Specifications. Notification from the manufacturer
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
-
Class II · last month
Mylan Pharmaceuticals Inc Carton label: Mycophenolate Mofetil for injection, USP recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Phosphate in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Mylan Pharmaceuticals Inc Prasugrel Tablets, USP, 10mg recall: Failed Dissolution Specifications; product failed to meet 18-month stability
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
-
Class III · last month
Chiesi USA, Inc. Revcovi Injection, 2.4mg/1.5mL , Single-Dose Vial recall: Failed Stability Specifications: Out of specification stability result
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
-
Class II · last month
Sage Products, LLC 2% Chlorhexidine Gluconate* Cloth, Non-sterile recall: Cross Contamination with Other Products
Cross Contamination with Other Products
-
Class II · last month
Baxter Healthcare Corporation Vasopressin, in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Vancomycin Injection, USP, in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Famotidine Injection in Sodium Chloride Injection, 20 mg recall: CGMP Deviations
CGMP Deviations
-
Class III · last month
Bionpharma Inc. Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · last month
Baxter Healthcare Corporation Myxredlin, Insulin Human in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Lexia LLC Broadway Joe's Pain Cream, 3000 gm CBD, ,4 oz-jar recall: CGMP Deviations: Potential contamination of raw material
CGMP Deviations: Potential contamination of raw material
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 20ml - 0.7 fl. oz. Tube recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Baxter Healthcare Corporation Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Allies Group Inc. THE ONE SPF 50 Invisible Sunscreen GEL, , 50ML - 1.7 fl. oz Tube recall: Subpotent Product: Firm Testing indicated the affected product
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Nexterone , 360 mg/200 mL in Galaxy Single-Dose recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Baxter Healthcare Corporation Daptomycin, in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
-
Class II · last month
Lexia LLC Broadway Joe's Pain Cream, , 1500mg CBD Isolate, 1000mg Hempseed oil recall: CGMP Deviations: Potential contamination of raw material
CGMP Deviations: Potential contamination of raw material
-
Class II · last month
Baxter Healthcare Corporation Pantoprazole Sodium in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations